FDA Inspection 1162930 — Baxco Pharmaceutical Inc.
The FDA completed an inspection of Baxco Pharmaceutical Inc. on February 17, 2022 in Duarte, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Duarte, CA (United States)